Clinical Trial

Comparison of Ganglion Impar Radiofrequency Ablation and Phenol Neurolysis Techniques for Chronic Coccydynia Treatment

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated June 17, 2025 (before its estimated November 2025 completion). Its status may not reflect the trial's current state.
Summary
Radiofrequency ablation and phenol neurolysis of the ganglion impar are methods used in cases unresponsive to medication, particularly in patients who derive short-term or partial relief from the initial ganglion impar block. In clinical practice, clinicians frequently use these two injections in patients with treatment-resistant pain who only partially benefit from the initial blockade procedure. To date, the medical literature lacks a comprehensive study comparing the efficacy of radiofrequency ablation and phenol neurolysis in patients who partially benefit from ganglion impar block. Therefore, this study is designed to compare the effectiveness of these two methods in patients with chronic coccydynia.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-06-10.
Trial Details
NCT Number NCT07021365
Lead Sponsor Marmara University
Conditions Coccygodynia, Coccydynia
Enrollment 30 participants
Start Date 2025-07
Primary Completion 2025-11 (estimated)
Study Completion 2026-03 (estimated)
Updated on ClinicalTrials.gov 2025-06-17